Doctoral thesis in structure-based drug design in diabetes at the Helmholtz Zentrum München, Munich (Germany)
Job Details The need for new and more effective drugs for type 2 diabetes is a major health concern. A doctoral thesis project is available at the Institute of Structural Biology. The main objective of this project is to discover new selective compounds targeting proteins relevant in type 2 diabetes using structure-based approaches. Qualifications - We are looking for a highly motivated candidate who has interest in protein expression, structural biology (NMR and X-ray crystallography), diabetes and drug design. - Applicants should have a Diploma or Master’s degree in Biochemistry with an above-average grade, and practical experience in basic methods of molecular biology and protein biochemistry. - Previous experience in NMR, crystallography or drug design is a plus. - The candidate must be innovative, highly motivated, and with a strong interest in team work. - Strong communication and organizational skills are expected. Inquiries should be addressed to Dr. Ana Messias (ana.mess...@helmholtz-muenchen.de) or Prof. Michael Sattler (satt...@helmholtz-muenchen.de) ------------------------------------------------------- Dr. Ana Messias Helmholtz Zentrum München Institute of Structural Biology (Building 43b, room 103) Ingolstädter Landstr. 1 85764 Neuherberg Germany Tel: +49 (0)89 3187- 4706 (office) / - 3732 (lab) E-mail: ana.mess...@helmholtz-muenchen.de ------------------------------------------------------- Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Ingolstädter Landstr. 1 85764 Neuherberg www.helmholtz-muenchen.de Aufsichtsratsvorsitzende: MinDir´in Bärbel Brumme-Bothe Geschäftsführer: Prof. Dr. Günther Wess und Dr. Nikolaus Blum Registergericht: Amtsgericht München HRB 6466 USt-IdNr: DE 129521671
